Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting

OBJECTIVE: To assess the cost effectiveness of once weekly rifapentine and isoniazid for 12 weeks (3HP) to the current standard care for latent tuberculosis (TB) infection (LTBI) in Iqaluit, Nunavut. DESIGN: A cost-effectiveness analysis using a Markov model reflecting local practices for LTBI treat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open
Asıl Yazarlar: Pease, Christopher, Alvarez, Gonzalo, Mallick, Ranjeeta, Patterson, Mike, Finn, Sandy, Habis, Yahya, Schwartzman, Kevin, Kilabuk, Elaine, Mulpuru, Sunita, Zwerling, Alice
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Infectious Diseases
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126298/
https://ncbi.nlm.nih.gov/pubmed/33986067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-047514
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller